Related Experiment Video For amphicrine-like carcinoma
Updated: Aug 6, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Gastrointestinal conventional carcinoma with neuroendocrine differentiation: From pathological phenomenon to clinical
Chenyang Zhou1, Shizheng Tong1, Danfeng Zhou2
1Department of Hepatobiliary Medicine, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.
Abstract:
Conventional carcinomas that lack neuroendocrine morphological features but display detectable expression of neuroendocrine markers through immunohistochemistry are termed conventional carcinomas with neuroendocrine differentiation (NED). Distinguishing these from mixed neuroendocrine non-neuroendocrine neoplasms and amphicrine-like carcinomas is important in accurate diagnosis and clinical management. The present review systematically outlines the advancements in research on gastrointestinal conventional carcinomas with NED, focusing on their characteristics, diagnostic criteria and clinical features. The present review further summarizes the epidemiological and clinical aspects across numerous organs such as the stomach and colorectum, emphasizing common mechanisms and prognostic variability. The future prospects of gastrointestinal conventional carcinomas with NED are also discussed, concentrating on key mechanisms, molecular subtypes and ongoing clinical trials to influence future research and clinical practices.